| 3CLpro | 3-chymotrypsin-like proteases |
| 3D | Three-dimensional |
| 3-P | 3′-processing |
| 3TC | Lamivudine |
| 5-CITEP | 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)propenone |
| ABT | ABT199/venetoclax |
| ACE2 | Angiotensin-converting enzyme 2 |
| ACV | Acyclovir |
| ACV | Acyclovir |
| ADE | Antibody-dependent enhancement |
| AI | Artificial Intelligence |
| ALLINI | Allosteric IN inhibitors |
| APV | Amprenavir |
| ART | Antiretroviral therapy |
| ASV | Asunaprevir |
| ATV | Atazanavir |
| BH | Berbamine hydrochloride |
| BIC | Bictegravir |
| BOC | Boceprevir |
| BVDU | Brivudine |
| BXA | Baloxavir |
| CAPE | Caffeic acid phenethyl ester |
| CAR | Coxsackievirus and Adenovirus Receptor |
| cART | Combination antiretroviral therapy |
| CCR5 | C-C chemokine receptor type 5 |
| CD4 | Cluster of differentiation 4 |
| CEN | Cap-dependent endonuclease |
| CHIKV | Chikungunya Virus |
| CLR | C-type lectin receptor |
| CMV | Cucumber Mosaic Virus |
| COVID-19 | Coronavirus disease 2019 |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| cryo-EM | Cryo-electron microscopy |
| Cryo-ET | Cryo-electron tomography |
| CsA | Cyclosporin A |
| CVB4 | Coxsackie B4 virus |
| CXCR4 | C-X-C chemokine receptor type 4 |
| Cyp | Cyclophilin |
| d4T | Stavudine |
| DC-SIGN | Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin |
| DdDp | DNA-Dependent DNA Polymerase |
| DdRp | DNA-Dependent RNA Polymerase |
| DENV | Dengue Virus |
| DKA | Diketoacid |
| DLV | Delavirdine |
| DNA | Deoxyribonucleic Acid |
| DOR | Doravirine |
| DPV | Dapivirine |
| DRV | Darunavir |
| dT | Deoxythymidine |
| DTG | Dolutegravir |
| EFV | Efavirenz |
| ENS | Ensitrelvir |
| ETR | Etravirine |
| EUA | Emergency use authorization |
| FDA | Food and Drug Administration |
| FVP | Favipiravir |
| G3BP1 | Ras GTPase-activating protein SH3-domain-binding protein 1 |
| GLE | Glecaprevir |
| GTase | m7GTP transferase |
| GV | Giant viruses |
| GZR | Grazoprevir |
| HA | hemagglutinin |
| HBV | Hepatitis B Virus |
| HC | Herbacetin |
| HCoV | Human Coronavirus- |
| HCV | Hepatitis C Virus |
| HHV | Human Herpesvirus |
| HIV | Human Immunodeficiency Virus |
| HPV | Human Papillomavirus |
| HS | heparan sulfate |
| HTLV | Human T-Cell Leukemia Virus |
| IBD | Integrase binding domain |
| ICTV | International Committee on Taxonomy of Viruses |
| IDP | Intrinsically disordered proteins |
| IDR | Intrinsically disordered regions |
| IDU | Idoxuridine |
| IDV | Indinavir |
| IFN | Interferon |
| IFN | Interferon |
| IL-10 | Interleukin 10 |
| IN | Integrase |
| INSTI | Integrase strand transfer inhibitors |
| INT | Intasome |
| IQM | Imiquimod |
| IR | Infrared |
| ISG | Interferon-Stimulated Genes |
| KSHV | Kaposi‘s Sarcoma-Associated Herpesvirus |
| LEDGF/p75 | Lens Epithelium-Derived Growth Factor/p75 |
| LPV | Lopinavir |
| MCV or MCPyV | Merkel Cell Polyomavirus |
| MD | Molecular Dynamics |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| MINI | Multimerization-selective integrase inhibitor |
| MOV | Molnupiravir |
| Mpro | Main protease |
| MPXV | Monkeypox virus |
| MTase | Methyltransferase |
| MXRA8 | Matrix remodeling-associated protein 8 |
| NA | Neuraminidase |
| NFV | Nelfinavir |
| NiRAN | RdRp-associated nucleotidyltransferase |
| NMR | Nuclear Magnetic Resonance |
| NMV | Nirmatrelvir |
| NNRTI | Non-nucleoside reverse transcriptase inhibitors |
| NRTI | Nucleoside reverse transcriptase inhibitors |
| NTD | N-terminal domain |
| NTD | N-terminal domain |
| NTP | Nucleoside triphosphate |
| NVP | Nevirapine |
| PCV | Penciclovir |
| PDX | Podofilox |
| PFA | Foscarnet |
| PI | Peptide inhibitors |
| PIC | Pre-integration complex |
| PLpro | Papain-like protease |
| PPI | Protein–protein interactions |
| PRF | Programmed ribosomal frameshifting |
| PT | Ponatinib |
| PVY | Potato Virus Y |
| RABV | Rabies Virus |
| RBD | Receptor-binding domain |
| RdRp | RNA-Dependent RNA Polymerase |
| RDV | Remdesivir |
| RNA | Ribonucleic Acid |
| RNase | Ribonuclease |
| RNP | Ribonucleoprotein |
| RPV | Rilpivirine |
| RSV | Respiratory syncytial virus |
| RT | Reverse Transcriptase |
| RTV | Ritonavir |
| RV | Rotavirus |
| SAH | S-adenosyl homocysteine |
| SAM | S-adenosyl-l-methionine |
| SARS-CoV | Severe Acute Respiratory Syndrome Coronavirus |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| SAXS | Small Angle X-ray Scattering |
| SBDD | Structure-based drug design |
| SERM | Selective estrogen receptor modulators |
| SG | Stress granule |
| SINE | Sinecatechins |
| SINV | Sindbis Virus |
| SMV | Simeprevir |
| SQV | Saquinavir |
| ST | Strand transfer |
| TBSV | Tomato bushy stunt virus |
| TDF | Tenofovir disoproxil fumarate |
| TEM | Transmission electron microscopy |
| TK | Thymidine kinase |
| TMV | Tobacco Mosaic Virus |
| TPV | Tipranavir |
| TVR | Telaprevir |
| VEEV | Venezuelan Equine Encephalitis virus |
| VLP | Virus-like particle |
| VOX | Voxilaprevir |
| VPV | Vaniprevir |
| VZV | Varicella-zoster virus |
| WHO | World Health Organization |
| XFEL | X-ray Free Electron Laser |
| XRD | X-ray diffraction |